EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The Evolving Landscape of CHD Genetics: A Contemporary Guide to Genetic Testing and Management

Bridget R O'Malley, Gary F Sholler, Janine Smith, Gillian M Blue

Journal of Paediatrics and Child Health · 21.08.2025

DOI: 10.1111/jpc.70176 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Paediatrics and Child Health, online erschienen am 21.08.2025. Verfasst von Bridget R O'Malley und 3 weiteren Autor:innen. Beteiligte Einrichtung: The Heart Centre for Children, Sydney Children's Hospitals Network, Sydney, New South Wales, Australia. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Heart Foundation of Australia, NSW Cardiovascular EMCR Grant.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Congenital heart disease (CHD) is the most common birth defect, affecting an estimated 9.4/1000 infants globally. The genetics of CHD is complex, with most cases thought to have multifactorial aetiology, implicating both genetic and environmental factors. Over the last decade, advances in genomic technologies have enabled significant discoveries in the field, with over 170 genes associated with human CHD to date. Further, the diagnostic yield in some patient subgroups is now comparable with other monogenic diseases such that genetic testing is increasingly part of routine CHD care with greater clinical utility. In line with these advances, genetic testing recommendations have been developed to inform and facilitate appropriate genetic testing in CHD patients, including who, when, why, and how to test. In this review, we explore the current understanding of the CHD genetics landscape and how this has evolved, also with respect to the often‐evidenced comorbidities present in many patients, including those with syndromic presentations. We discuss practical considerations of genetic testing in CHD, including the type and timing of the testing, diagnostic yields across specific patient groups, patients most likely to benefit from the testing, psychosocial impacts, and the broader implications on clinical care and management. Further, we outline the value and utility of genetic testing for patients and families in line with our experience at the first paediatric CHD genetic clinic in Australia. Finally, we explore future directions for genetic testing in CHD, including the applicability and appropriateness of universal genetic testing in the prenatal and neonatal setting.

Autor:innen und Institutionen

  • The Heart Centre for Children, Sydney Children's Hospitals Network, Sydney, New South Wales, Australia.
  • The Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.
  • Department of Clinical Genetics, The Children's Hospital at Westmead, Sydney, New South Wales, Australia.

Förderung

  • National Heart Foundation of Australia
  • NSW Cardiovascular EMCR Grant

Zitieren

APA

O'Malley, B. R., Sholler, G. F., Smith, J., & Blue, G. M. (2025). The Evolving Landscape of CHD Genetics: A Contemporary Guide to Genetic Testing and Management. Journal of Paediatrics and Child Health. https://doi.org/10.1111/jpc.70176

Vancouver

O'Malley BR, Sholler GF, Smith J, Blue GM. The Evolving Landscape of CHD Genetics: A Contemporary Guide to Genetic Testing and Management. Journal of Paediatrics and Child Health. 2025. doi:10.1111/jpc.70176

BibTeX
@article{OMalley2025,
  author = {O'Malley, Bridget R and Sholler, Gary F and Smith, Janine and Blue, Gillian M},
  title = {The Evolving Landscape of CHD Genetics: A Contemporary Guide to Genetic Testing and Management},
  journal = {Journal of Paediatrics and Child Health},
  year = {2025},
  doi = {10.1111/jpc.70176}
}
Kostenlos starten →